Speaker illustration

Associate Professor Davide Castagno

University of Turin, Turin (Italy)

Member of:

European Society of Cardiology
European Heart Rythm Association
Heart Failure Association

Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience

Event: EHRA 2024

Topic: Treatment

Session: Devices: bradycardia 4

Thumbnail

Vascular access in cardiac implantable electronic devices: a systematic review and network meta-analysis.

Event: ESC Congress 2023

Topic: Device Complications and Lead Extraction

Session: Device complications and lead extraction

Thumbnail

Role of the implantable loop recorder in clinical practice: insights on indications, diagnostic yield and therapeutic implications from a single, high volume, tertiary care centre experience

Event: EHRA 2023

Topic: Invasive Diagnostic Methods

Session: ePoster session 29

Thumbnail

Use, indications and diagnostic yield of implantable loop recorder in clinical practice: a single, high volume, tertiary care centre experience.

Event: ESC Congress 2020

Topic: Diagnostic Methods

Session: Arrhythmias, General ePosters

Thumbnail

Trends in heart failure epidemiology between 2007 and 2016 in Piedmont, Italy: findings from the Epi-HF study

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: long-term results and clinical outcomes.

Event: ESC Congress 2017

Topic: Catheter ablation

Session: Catheter ablation

Thumbnail

Impact of different left bundle branch definitions on cardiac resynchronization therapy response and clinical outcomes

Event: ESC Congress 2016

Topic: Electrocardiography

Session: Tools to reduce ventricular arrhythmic in cardiac resynchronisation therapy patients and miscellaneous

Thumbnail

Prognostic importance of heart rate, and effect of sacubitril/valsartan according to heart rate, in PARADIGM-HF

Event: HEART FAILURE 2016

Topic: Prognosis

Session: Prognosis

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb